International Murex Technologies Corp. announced Friday thatit has closed the sale of 710,800 units, grossing $3.7 million.
The Canadian company, which recently moved its headquartersto Norcross, Ga., began selling the units on July 7 outside theU.S. to "non-U.S. persons and institutions," primarily in Europe.
This placement was faster than going through U.S. registration,said spokeswoman Marcia Young, especially for a relativelysmall financing.
The money will be used for general corporate purposes,allowing the company (ASE:MXX) to license in sometechnologies, she said. The company last licensed in DNA probetechnology in April.
The offering consisted of units comprised of one common shareand half a share purchase warrant. Each unit was priced at$5.25. A full warrant allows the holder to purchase onecommon share for $5.78 through July 17, 1995.
IMTC's stock closed at $4.38 a share on Monday, down 13 cents.
(c) 1997 American Health Consultants. All rights reserved.